Metride DS 3 Tablet PR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
-10%
Dazolic 500mg Tablet
Original price was: ₹158.00.₹142.20Current price is: ₹142.20.
Posmeal-Met 0.2 Tablet SR
Original price was: ₹109.31.₹98.38Current price is: ₹98.38.
Metride DS 3 Tablet PR
Original price was: ₹168.50.₹151.65Current price is: ₹151.65.
Description
Reviews (0)
Related products
Baidyanath Maharasnadi Kadha Syrup | Protects Against Vata Roga
Original price was: ₹242.00.₹217.00Current price is: ₹217.00.
Baidyanath Rumartho Tablet
Original price was: ₹251.00.₹226.00Current price is: ₹226.00.
Dabur Ashokarishta
Original price was: ₹82.30.₹74.07Current price is: ₹74.07.
Dabur Khadiradi Gutika
Original price was: ₹73.00.₹65.70Current price is: ₹65.70.
Dabur Lal Tail 100ml
Original price was: ₹117.00.₹105.30Current price is: ₹105.30.
Dabur Lasunadi Vati
Original price was: ₹74.00.₹66.60Current price is: ₹66.60.
- It assists in the treatment of digestive disorders such as indigestion, loss of appetite, and vomiting
- It comes with carminative properties
- It helps in stimulating the digestive system
- It provides relief in the case of stomach pain
- It is beneficial in treating Diarrhoea associated with vomiting, gas, and griping pai
Dabur Pilochek Gel
Original price was: ₹78.00.₹70.20Current price is: ₹70.20.
Dabur Rheumatil Gel
Original price was: ₹100.00.₹90.00Current price is: ₹90.00.
- Ayurvedic Formulation: Combines traditional formulas like Mahanarayana tail and herbs like Mentha Piperita and Cinnamomum Camphora known for their pain-relieving properties
- Versatile Use: May be effective for reducing joint pain
- Cooling Effect: Offers a soothing and cooling sensation that may help in reducing inflammation and discomfort
- Convenient Application: Easy to apply and absorb, making it suitable for regular use in managing joint and muscle pain
Reviews
There are no reviews yet.